Larvol Delta - ABL-Biowill-unveil-at-the-meeting-its-bispecic-antibody-technology-that-targets-cancer-cells-and-immune-cells-simultaneously

givastomig (TJ-CD4B) - NovaBridge Biosciences, ABL Bio

ragistomig (ABL503) - ABL Bio, NovaBridge Biosciences

https://biz.chosun.com/en/en-science/2026/08/19/J67USKRYTRGFTNBYY3LZ2HLHVE/

Aug 19, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next